![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Using Laboratory Data to Predict Long-Term Morbidity and Mortality in Chronic Hepatitis C (& treatment affect) Patients in the U.S. Veterans Health Administration
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
McCombs JS1, Matsuda T1,2, Mihara I2, Saab S3, Hines P4, L'Italien G4, Juday T4, Yuan Y4 1Department of Clinical Pharmacy and Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA 2Veterans Health Administration Hospital, Long Beach, CA, USA 3David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA 4Global Health Economics and Outcomes Research, Bristol-Myers Squibb, Princeton, NJ, USA
![AASLD1.gif](../images/120413/120413-13/AASLD1.gif)
![AASLD2.gif](../images/120413/120413-13/AASLD2.gif)
![AASLD3.gif](../images/120413/120413-13/AASLD3.gif)
![AASLD4.gif](../images/120413/120413-13/AASLD4.gif)
![AASLD5.gif](../images/120413/120413-13/AASLD5.gif)
![AASLD6.gif](../images/120413/120413-13/AASLD6.gif)
![AASLD7.gif](../images/120413/120413-13/AASLD7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|